Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
9 Patents
#68 in Lexington, MA
#1,926 in Massachusetts
#32,588 in US
Kaleido Biosciences, Inc.
Forward Citations = 104
11 inventors:
Lexington, MA, United States of America
Kaleido Biosciences, Inc.
EPO Patents = 3
Trademarks = 2
Forward Citations = 104
Loading Chart...
Loading Chart...
11 inventors (with patents filed for the assignee):
John M Geremia (9 out of 30 patents)
Geoffrey Von Maltzahn (8 out of 104 patents)
Jared Silverman (8 out of 15 patents)
4. Yvonne J Yamanaka (8 out of 10 patents)
5. John Miles Milwid (8 out of 15 patents)
6. Christopher Matthew Liu (1 out of 9 patents)
7. Anastasia Lioubomirov (1 out of 2 patents)
8. Mitchell Antalek (1 out of 1 patent)
9. Jonathan Lawrence (1 out of 2 patents)
10. Tatyana Yatsunenko (1 out of 1 patent)
11. Brian Meehan (1 out of 1 patent)
12. Jacob Rosenblum Rubens (1 out of 17 patents)
13. Jack Milwid (2 patents)
9 patents:
Company Overview
Kaleido Biosciences is a clinical-stage healthcare company pioneering the development of a new class of medicines based on the potential of the human microbiome. Kaleido's Microbiome Metabolic Therapy platform is designed to optimize the intestinal microbiome to treat disease and improve human health.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kaleido Biosciences, Inc.. Retrieved from https://idiyas.com/company/kaleido-biosciences
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]